Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00972153 · ClinicalTrials.gov registry record · NA

Device to Reduce Surgery Site Contamination

A NA study of Surgery, sponsored by Nimbic Systems.

Completed
Registry status
NA
Development phase
29
Enrollment target
1
Study location

NCT00972153: Completed NA study of Surgery, sponsored by Nimbic Systems.

NCT00972153 is a NA study of Surgery that has completed, run by Nimbic Systems. The registered enrollment target is 29 participants, below the 52,852-participant average among 120 other Surgery trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00972153, a NA study of Surgery, has completed, sponsored by Nimbic Systems.

COMPLETED
Registry status
NA
Development phase
29 participants
Enrollment target
1
Study location

Study Summary

The objective of this study is to determine whether the Air Barrier System device reduces airborne particulate and airborne colony forming units present at a surgery site.

Primary Outcome

Colony forming unit counts were collected from the air within 5 cm of the surgical wound using a bioaerosol "slit" sampling device. Air was drawn through a sterile PVC tubing located at the incision and impacted upon media (TSA 5% sheep's blood) plates located in the sampling device. The plates were exchanged every 10 minutes throughout the procedure. Values are presented as CFU/cubic meter.

Conditions Studied

Interventions

  • DEVICE Air Barrier System Device
  • DEVICE Sham Air Barrier System device

Study Locations (1)

Texas

  • Texas Orthopedic Hospital - Houston

Trial Details

FieldValue
Enrollment Target 29 participants
Start Date 2009-05
Est. Completion 2009-09
Phase NA
Nimbic Systems

4 total trials

What the finished NCT00972153 record still lists

NCT00972153 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 29 participants, a relatively small participant target, below the 52,852-participant average among 120 other Surgery trials with a reported enrollment target (100% lower).

The record links to 1 condition, with Surgery appearing as the primary indexed condition, and to 2 interventions - of which Air Barrier System Device is the first listed.

NCT00972153 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT00972153 about?

NCT00972153 is a clinical study titled "Device to Reduce Surgery Site Contamination". The objective of this study is to determine whether the Air Barrier System device reduces airborne particulate and airborne colony forming units present at a surgery site.

What is the current status of trial NCT00972153?

This trial is currently completed. It is a NA study. The enrollment target is 29 participants. The study started on 2009-05. Estimated completion is 2009-09.

What conditions does trial NCT00972153 study?

This clinical trial studies the following conditions: Surgery.

What interventions are being tested in trial NCT00972153?

The interventions under investigation include: Air Barrier System Device (DEVICE), Sham Air Barrier System device (DEVICE).

Who is sponsoring clinical trial NCT00972153?

This trial is sponsored by Nimbic Systems, which has 4 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00972153 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Surgery

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00972153's enrollment target sits among peer trials

29 113th of 120 higher than 8 of 120 other Surgery trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Surgery trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02429557 · 29 participants · Phase 1

    Hemodynamic Mechanisms of Abdominal Compression in the Treatment of Orthostatic Hypotension in Autonomic Failure

  • NCT02568878 · 29 participants · Phase 3

    Creatine for Depressed Male and Female Methamphetamine Users

  • NCT03014401 · 29 participants · NA

    The Effect of Adipose-Derived Stem Cells for Knee Osteoarthritis

  • NCT03128996 · 29 participants · Phase 1

    Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00972153, the US trial registry maintained by the National Library of Medicine. NCT00972153 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.